Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.250
-0.020 (-1.57%)
Dec 3, 2024, 1:54 PM EST - Market open
Atossa Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 3, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 157 | 110 | 67 | 203 | 37 | 14 | |
| Market Cap Growth | 106.34% | 64.77% | -66.97% | 445.88% | 158.90% | 148.91% | |
| Enterprise Value | 85 | 17 | -50 | 63 | 29 | -0 | |
| Last Close Price | 1.27 | 0.88 | 0.53 | 1.60 | 0.95 | 1.57 | |
| PB Ratio | 2.17 | 1.21 | 0.57 | 1.47 | 1.37 | 1.09 | |
| P/TBV Ratio | 2.59 | 1.21 | 0.57 | 1.47 | 1.40 | 1.15 | |
| Debt / Equity Ratio | - | - | - | - | 0.00 | 0.00 | |
| Quick Ratio | 12.90 | 16.89 | 20.05 | 43.97 | 2.56 | 10.07 | |
| Current Ratio | 13.30 | 17.61 | 21.23 | 45.18 | 2.73 | 10.83 | |
| Return on Equity (ROE) | -31.30% | -28.80% | -21.05% | -24.93% | -88.42% | -157.00% | |
| Return on Assets (ROA) | -20.35% | -17.85% | -13.07% | -13.93% | -31.85% | -82.34% | |
| Return on Capital (ROIC) | -21.44% | -18.77% | -13.52% | -15.52% | -45.20% | -98.05% | |
| Earnings Yield | -16.84% | -27.29% | -40.29% | -10.17% | -48.04% | -120.26% | |
| FCF Yield | -12.25% | -19.00% | -31.06% | -8.13% | -31.20% | -63.73% | |
| Buyback Yield / Dilution | 0.70% | 0.43% | -8.27% | -934.13% | -33.09% | -104.36% | |
| Total Shareholder Return | 0.70% | 0.43% | -8.27% | -934.13% | -33.09% | -104.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.